References
- Torrance GW, Thomas WH, Sackett D. A utility maximization model for evaluation of health care programs. Health Serv Res 1972;7:118-133
- Torrance GW. Measurement of health state utilities for economic appraisal. A review. J Health Econ 1986;5:1-30
- Academy of Managed Care Pharmacy. Format for Formulary Submissions (Version 3.0). Alexandria, VA, 2009
- Chancellor J, Aballea S, Lawrence Al, et al. Preferences of patients with diabetes mellitus for inhaled versus injectable insulin regimens. Pharmacoeconomics 2008;26:217-234
- Huang ES, Brown SES, Ewigman BG, et al. Patient perceptions of quality of life with diabetes-related complications and treatments. Diabetes Care 2007;30:2478-2483
- Peyrot M, Rubin RR. How does treatment satisfaction work? Diabetes Care 2009;32:1411-1417
- Gallwitz B. Glucagon-like peptide−1-based therapies for the treatment of type 2 diabetes mellitus. Treat Endocrinol 2005;4:361-70
- Nathan DM, Buse JB, Davidson MB, et al. Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy. Diabetes Care 2008;31:1-11
- National Institute for Health and Clinical Excellence. Guide to the Methods of Technology Appraisal. National Institute for Health and Clinical Excellence, England (UK) 2004 (cited 2009 Jan 20) Available from: http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf
- Weinstein MC, Siegel JE, Gold MR, et al. Recommendations of the panel on cost-effectiveness in health and medicine. JAMA 1996;276:1253-1258
- Brooks R, Rabin R, de Charro F. The measurement and valuation of health status using EQ-5D: a European perspective. Dordrecht: Kluwer Academic Publishers, 2003
- Rabin R, de Charro F. EQ-5D: a measure of health status from the EuroQol Group. Ann Med 2001;33:337-343
- King JT, Styn MA, Tsevat J, et al. ‘Perfect health’ versus ‘disease free’: the impact of anchor point choice on the measurement of preferences and the calculation of disease-specific disutilities. Med Decis Making 2003;23:212-225
- Wittrup-Jensen KU, Lauridsen J, Gudex C, et al. Generation of a Danish TTO value set for EQ-5D health states. Scand J Public Health, 2009;37:459-466
- Arnesen T, Trommald M. Are QALYs based on time trade-off comparable? – A systematic review of TTO methodologies. Health Econ 2004;14:39-53
- Stiggelbout AM, Kiebert GM, Kievit J, et al. The ‘utility’ of the time trade-off method in cancer patients: feasibility and proportional trade-off. J Clin Epidemiol 1995;48:1207-1214
- Buse J, Rosenstock J, Sesti G, et al. Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6). Lancet 2009;374:39-47
- Rossi PE, Allenby GM, McCulloch R. Bayesian Statistics and Marketing. Marketing Science 2003;22:304-28
- O’Brien B. Principles of economic evaluation for healthcare programs. J Rheumatol 1995;7:1399-1402
- Matza LS, Boye KS, Yurgin N, et al. Utilities and disutilities for type 2 diabetes treatment-related attributes. Qual Life Res 2007;16:1251-1265
- Allenby GM, Rossi PE. Marketing models of consumer heterogeneity. J Econom 1999;89:57-78
- Saydah SH, Fradkin, J, Cowie, CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 2004;291:335-342
- Clarke P, Gray A, Holman R. UKPDS 62. Estimating utility values for health states of type 2 diabetic patients using the EQ-5D. Med Decis Making 2002;22:340-349
- Hunot VM, Horne R, Leese MN, et al. A cohort study of adherence to antidepressants in primary care: the influence of antidepressant concerns and treatment preferences. prim care companion. J Clin Psychiatry 2007;9:91-99
- Raue PJ, Schulberg HC, Heo M, et al. Patient preferences for depression treatment and initiation, adherence, and outcome: a randomized study in primary care. Psychiatr Serv 2009;60:337-343
- Brown GC, Brown MM, Sharma S, et al. Quality of live associated with diabetes mellitus in an adult population. J Diabetes Complications 2000;14:18-24
- Kahneman D, Tversky A. Prospect theory: an analysis of decision under risk. Econometrica 1979;47:263-292
- Bleichrodt H, Pinto JL, Abellan-Perpinan JM. A consistency test of the time trade-off. J Health Econ 2003;22:1037-1052
- Buckingham JK, Birdsall J, Douglas JG. Comparing three version of the time tradeoff: time for a change? Med Decis Making 1996;16:335-347